Aligos Therapeutics (ALGS) Capital Leases (2019 - 2025)
Aligos Therapeutics' (ALGS) quarterly Capital Leases came in at $122000.0 in Q3 2025, down 35.11% YoY from $188000.0 in Q3 2024, and little changed on a QoQ basis from $122000.0 in Q2 2025.
Aligos Therapeutics (ALGS) Capital Leases (2019 - 2025) Analysis & Trends
Aligos Therapeutics (ALGS) has 7 years of Capital Leases data on file, last reported at $122000.0 in Q3 2025.
- Quarterly Capital Leases fell 35.11% year-over-year to $122000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $122000.0 (down 35.11% YoY) and the FY2024 annual result came in at $122000.0, down 47.19% from the prior year.
- Capital Leases held at $122000.0 in Q3 2025, from $122000.0 in the prior quarter.
- In the past five years, Capital Leases ranged from a high of $261000.0 in Q4 2021 to a low of $53000.0 in Q3 2021.
- A 5-year average of $175421.1 and a median of $188000.0 in 2023 frame the typical range for Capital Leases.
- Annual changes were most pronounced in 2021 — Capital Leases slumped 59.23% — and 2022, when it soared 228.3%.
- Tracing ALGS's Capital Leases over 5 years: stood at $261000.0 in 2021, then declined by 11.88% to $230000.0 in 2022, then climbed by 0.43% to $231000.0 in 2023, then slumped by 47.19% to $122000.0 in 2024, then changed by 0.0% to $122000.0 in 2025.
- The last three Capital Leases figures came in at $122000.0 (Q3 2025), $122000.0 (Q2 2025), and $122000.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.82 Bn | 131.97 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.70 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.23 Bn | 60.05 Bn | 1.37 Bn |
| 4 | Moderna | 60.16 Bn | 55.02 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.16 Bn | 37.07 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.86 Bn | 28.55 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.24 Bn | 9.85 Bn | 668.28 Mn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - |
| 10 | Aligos Therapeutics | 70.30 Mn | 39.86 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 122,000.00 |
| Jun 30, 2025 | 122,000.00 |
| Mar 31, 2025 | 122,000.00 |
| Dec 31, 2024 | 122,000.00 |
| Sep 30, 2024 | 188,000.00 |
| Jun 30, 2024 | 203,000.00 |
| Mar 31, 2024 | 217,000.00 |
| Dec 31, 2023 | 231,000.00 |
| Sep 30, 2023 | 188,000.00 |
| Jun 30, 2023 | 203,000.00 |
| Mar 31, 2023 | 205,000.00 |
| Dec 31, 2022 | 230,000.00 |
| Sep 30, 2022 | 174,000.00 |
| Jun 30, 2022 | 201,000.00 |
| Mar 31, 2022 | 231,000.00 |
| Dec 31, 2021 | 261,000.00 |
| Sep 30, 2021 | 53,000.00 |
| Jun 30, 2021 | 130,000.00 |
| Mar 31, 2021 | 130,000.00 |
| Dec 31, 2020 | 130,000.00 |